Dunn Andrew L, Reed Tameika, Stewart Charlotte, Levy Rebecca A
Department of Pathology, University of Arkansas for Medical Sciences, Little Rock.
Department of Pathology, Clinical Laboratory Arkansas Children's Hospital, Little Rock.
Lab Med. 2016 May;47(2):149-54. doi: 10.1093/labmed/lmw008. Epub 2016 Mar 15.
Primary amoebic meningoencephalitis (PAM) is a rare and almost always fatal disease that is caused by Naegleria fowleri, a freshwater thermophilic amoeba. Our case involves an adolescent female who presented with fever of unknown origin. A lumbar puncture was performed, and the Wright-Giemsa and Gram stained cerebrospinal fluid (CSF) cytospin slides showed numerous organisms. Experienced medical technologists in the microbiology and hematology laboratories identified the organisms as morphologically consistent with Naegleria species. The laboratory made a rapid diagnosis and alerted emergency department care providers within 75 minutes. The patient was treated for PAM with amphotericin, rifampin, azithromycin, fluconazole and aggressive supportive therapy including dexamethasone. The Centers for Disease Control and Prevention (CDC) was contacted, and miltefosine, an investigational medication, was started. Additional treatment included an intraventricular shunt and controlled hypothermia in order to mitigate potential cerebral edema. Our patient is a rare success story, as she was diagnosed swiftly, successfully treated, and survived PAM.
原发性阿米巴脑膜脑炎(PAM)是一种罕见且几乎总是致命的疾病,由嗜热淡水阿米巴福氏耐格里阿米巴引起。我们的病例是一名出现不明原因发热的青春期女性。进行了腰椎穿刺,瑞氏-吉姆萨染色和革兰氏染色的脑脊液(CSF)细胞离心涂片显示有大量微生物。微生物学和血液学实验室经验丰富的医学技术人员将这些微生物鉴定为形态上与耐格里属物种一致。实验室迅速做出诊断,并在75分钟内通知了急诊科医护人员。该患者接受了两性霉素、利福平、阿奇霉素、氟康唑治疗PAM,并接受了包括地塞米松在内的积极支持治疗。联系了疾病控制与预防中心(CDC),并开始使用试验性药物米替福新。额外的治疗包括脑室分流和控制性低温,以减轻潜在的脑水肿。我们的患者是一个罕见的成功案例,因为她被迅速诊断、成功治疗并从原发性阿米巴脑膜脑炎中存活下来。